期刊文献+

加味百合固金汤联合大承气汤对晚期肺癌合并肺炎患者炎症因子的影响 被引量:13

Study on Effect of Modified Baihe Gujin Decoction and Dachengqi Decoction on Inflammatory Factorsof Patients with Advanced Lung Cancer Complicated with Pneumonia
下载PDF
导出
摘要 目的探讨加味百合固金汤联合大承气汤对晚期肺癌合并肺炎患者炎症因子的影响。方法将2012年3月-2018年2月本院150例晚期肺癌合并肺炎患者,随机分两组,各75例,对照组采用常规基础治疗;在此基础上,观察组采用加味百合固金汤联合大承气汤治疗,1剂/d,两组患者持续治疗14 d。比较两组患者的临床疗效、降钙素原(Procalcitonin,PCT)、白细胞介素-6(Interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)及T淋巴细胞亚群,记录不良反应状况。结果对照组有效率84.00%低于观察组94.67%,差异具有统计学意义(P<0.05)。两组患者不同时间点血清PCT、IL-6、TNF-α及T淋巴细胞亚群比较,差异具有统计学意义(P<0.05)。治疗7 d对照组和观察组PCT为(8.64±3.12)、(6.17±2.57),IL-6为(34.15±10.21)、(25.10±9.85),TNF-α为(136.95±37.85)、(101.06±35.27),CD3^+为(48.31±4.35)、(52.61±4.89),CD8^+为(26.79±2.50)、(25.84±2.35),CD4^+/CD8^+为(1.36±0.16)、(1.46±0.17),治疗14 d对照组和观察组PCT为(5.67±2.41)、(4.10±2.13),IL-6为(23.31±8.10)、(16.53±7.69),TNF-α为(97.41±34.11)、(72.05±28.96),CD3^+为(53.59±5.10)、(57.42±5.31),CD8^+为(25.16±2.41)、(23.45±2.14),CD4^+/CD8^+为(1.45±0.17)、(1.69±0.20),对照组和观察组上述指标比较,差异具有统计学意义(P<0.05)。两组患者不良率比较,差异无统计学意义(P>0.05)。结论加味百合固金汤联合大承气汤对晚期肺癌合并肺炎患者的疗效确切,可以降低炎症因子,提高免疫功能,且患者可以耐受,安全性高。 Objective To investigate the effect of Modified Baihe Gujin Decoction combined with Dachengqi Decoction on inflammatory factors of patients with advanced lung cancer complicated with pneumonia.Methods Totally 150 patients with advanced lung cancer complicated with pneumonia in our hospital from March 2012 to February 2018 were randomly divided into two groups,75 cases in each group.The control group was treated with routine basic treatment and the observation group was treated with Modified Baihe Gujin Decoction combined with Dachengqi Decoction,one dose a day,and the two groups were treated continuously for 14 days.The clinical efficacy,procalcitonin(PCT),interleukin-6(IL6),tumor necrosis factor-alpha(TNF-alpha)and T lymphocyte subsets were compared between the two groups,and the adverse reactions were recorded.Results The effective rate of the control group(84.00%)was lower than the observation group(94.67%)(P<0.05).There were significant differences in serum levels of PCT,IL-6,TNF-alpha and T lymphocyte subsets between the two groups at different time points(P<0.05).Seven days after treatment,PCT levels of the control group and observation group were(8.64±3.12)ng/mL and(6.17±2.57)ng/mL.IL-6 levels were(34.15±10.21)pg/mL and(25.10±9.85)pg/mL.TNF-αlevels were(136.95±37.85)ng/mL and(101.06±35.27)ng/mL.CD3^+percentages were(48.31±4.35)%and(52.61±4.89)%.CD8^+percentages were(26.79±2.50)%and(25.84±2.35)%.The rations of CD4^+/CD8^+were1.36±0.16 and 1.46±0.17.Fourteen days aftertreatment,PCT levels of the control group and observation group(5.67±2.41)ng/mL and(4.10±2.13)ng/mL.IL-6 levels were(23.31±8.10)pg/mL and(16.53±7.69)pg/mL.TNF-αlevels were(97.41±34.11)ng/mL and(72.05±28.96)ng/mL.CD3^+percentages were(53.59±5.10)%and(57.42±5.31)%.CD8^+percentages were(25.16±2.41)%and(23.45±2.14)%.The rations of CD4^+/CD8^+were 1.45±0.17 and 1.69±0.20.All indexes in two groups had significant differences(P<0.05).There was no significant difference in the adverse rate between the two groups(P>0.05).Conclu
作者 李昊 LI Hao(Department of Integrated Traditional Chinese and Western Medicine,Tianjin Occupational Disease Prevention and Control Hospital,Tianjin 300011,China)
出处 《辽宁中医杂志》 CAS 2020年第4期101-104,共4页 Liaoning Journal of Traditional Chinese Medicine
基金 天津市科技计划项目(13022)。
关键词 加味百合固金汤 大承气汤 晚期肺癌 肺炎 炎症因子 免疫功能 Modified Baihe Gujin Decoction Dachengqi Decoction advanced lung cancer pneumonia inflammatory factor immune function
  • 相关文献

参考文献15

二级参考文献132

  • 1张艳玲,杨平,彭敏.清肺化痰汤治疗肺部感染临床疗效分析[J].辽宁中医药大学学报,2009,11(1):113-114. 被引量:4
  • 2支修益,陈东红.肺癌新TNM分期系统解析[J].中国医学前沿杂志(电子版),2010,2(3):32-35. 被引量:4
  • 3陈高峰,张念华.痰热清注射液治疗恶性肿瘤合并肺部感染疗效观察[J].江西中医药,2007,38(7):35-36. 被引量:10
  • 4陈灏珠.实用内科学[M]11版[M].北京:人民卫生出版社,2002.1367. 被引量:134
  • 5赵燕,杨树军,赵红星.非小细胞肺癌患者凝血功能变化及其临床意义[J].中国肿瘤临床,2007,34(21):1250-1252. 被引量:11
  • 6Saskia C.C.M. Teunissen,Wendy Wesker,Cas Kruitwagen,Hanneke C.J.M. de Haes,Emile E. Voest,Alexander de Graeff.Symptom Prevalence in Patients with Incurable Cancer: A Systematic Review[J]. Journal of Pain and Symptom Management . 2007 (1) 被引量:1
  • 7Liliana De Lima,Eric L. Krakauer,Karl Lorenz,David Praill,Neil MacDonald,Derek Doyle.Ensuring Palliative Medicine Availability: The Development of the IAHPC List of Essential Medicines for Palliative Care[J]. Journal of Pain and Symptom Management . 2007 (5) 被引量:1
  • 8Iuliana Caras,A. Grigorescu,Crina Stavaru,D. L. Radu,I. Mogos,G. Szegli,Aurora Salageanu.Evidence for immune defects in breast and lung cancer patients[J]. Cancer Immunology, Immunotherapy . 2004 (12) 被引量:1
  • 9Yihuai Gao,Wenbo Tang,Xihu Dai,He Gao,Guoliang Chen,Jinxian Ye,Eli Chan,Hwee Ling Koh,Xiaotian Li,Shufeng Zhou.Effects of Water-Soluble Ganoderma lucidum Polysaccharides on the Immune Functions of Patients with Advanced Lung Cancer. Journal of Medicinal Food . 2005 被引量:1
  • 10Nichols Larry,Saunders Rachel,Knollmann Friedrich D.Causes of death of patients with lung cancer. Archives of Pathology . 2012 被引量:1

共引文献126

同被引文献233

引证文献13

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部